Jonathan J. Lyon

671 total citations
16 papers, 517 citations indexed

About

Jonathan J. Lyon is a scholar working on Molecular Biology, Clinical Biochemistry and Organic Chemistry. According to data from OpenAlex, Jonathan J. Lyon has authored 16 papers receiving a total of 517 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 4 papers in Clinical Biochemistry and 2 papers in Organic Chemistry. Recurrent topics in Jonathan J. Lyon's work include Mitochondrial Function and Pathology (5 papers), Metabolism and Genetic Disorders (4 papers) and Bioactive Compounds and Antitumor Agents (2 papers). Jonathan J. Lyon is often cited by papers focused on Mitochondrial Function and Pathology (5 papers), Metabolism and Genetic Disorders (4 papers) and Bioactive Compounds and Antitumor Agents (2 papers). Jonathan J. Lyon collaborates with scholars based in United Kingdom, United States and Switzerland. Jonathan J. Lyon's co-authors include Nicholas B. La Thangue, Chang‐Woo Lee, Noriko Shikama, Stephen L. France, Laurent Delavaine, Marija Krstic–Demonacos, R J Watson, Roger J. Watson, Timothy W. Gant and Jinli Luo and has published in prestigious journals such as Molecular Cell, PLoS ONE and Pharmacological Reviews.

In The Last Decade

Jonathan J. Lyon

16 papers receiving 506 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jonathan J. Lyon United Kingdom 9 328 158 132 82 55 16 517
Ilaria Dalla Rosa United States 20 813 2.5× 194 1.2× 79 0.6× 81 1.0× 43 0.8× 26 994
N. Sadananda Singh India 14 440 1.3× 108 0.7× 126 1.0× 63 0.8× 75 1.4× 19 696
Pey Yee Lee Malaysia 11 360 1.1× 65 0.4× 32 0.2× 49 0.6× 32 0.6× 18 542
Paul Vichi United States 9 478 1.5× 176 1.1× 29 0.2× 33 0.4× 34 0.6× 10 618
Ine B. Tijdens Netherlands 10 337 1.0× 75 0.5× 20 0.2× 66 0.8× 100 1.8× 11 475
Maria Svetlova Russia 17 807 2.5× 181 1.1× 30 0.2× 262 3.2× 39 0.7× 40 1.1k
Parviz Behnam‐Motlagh Sweden 13 239 0.7× 101 0.6× 20 0.2× 50 0.6× 50 0.9× 23 423
Qiuqiong Tang China 13 357 1.1× 174 1.1× 27 0.2× 150 1.8× 13 0.2× 20 582
Dana Ravid Israel 8 403 1.2× 117 0.7× 28 0.2× 116 1.4× 337 6.1× 8 600
Stefan Loroch Germany 13 372 1.1× 55 0.3× 45 0.3× 77 0.9× 39 0.7× 21 648

Countries citing papers authored by Jonathan J. Lyon

Since Specialization
Citations

This map shows the geographic impact of Jonathan J. Lyon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan J. Lyon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan J. Lyon more than expected).

Fields of papers citing papers by Jonathan J. Lyon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan J. Lyon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan J. Lyon. The network helps show where Jonathan J. Lyon may publish in the future.

Co-authorship network of co-authors of Jonathan J. Lyon

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan J. Lyon. A scholar is included among the top collaborators of Jonathan J. Lyon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan J. Lyon. Jonathan J. Lyon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
2.
Hoogstraten, Charlotte A., Jonathan J. Lyon, Jan Smeıtınk, Frans G. M. Rüssel, & Tom J.J. Schirris. (2023). Time to Change: A Systems Pharmacology Approach to Disentangle Mechanisms of Drug-Induced Mitochondrial Toxicity. Pharmacological Reviews. 75(3). 463–486. 9 indexed citations
3.
O’Brien, Katie A., Ben D. McNally, Antonio Murgia, et al.. (2021). Enhanced hepatic respiratory capacity and altered lipid metabolism support metabolic homeostasis during short-term hypoxic stress. BMC Biology. 19(1). 265–265. 7 indexed citations
4.
Bloch, Katarzyna, Lucille Rainbow, Xuan Liu, et al.. (2021). Assessment of the impact of mitochondrial genotype upon drug-induced mitochondrial dysfunction in platelets derived from healthy volunteers. Archives of Toxicology. 95(4). 1335–1347. 5 indexed citations
5.
Kamalian, Laleh, et al.. (2016). Identification of the Additional Mitochondrial Liabilities of 2-Hydroxyflutamide When Compared With its Parent Compound, Flutamide in HepG2 Cells. Toxicological Sciences. 153(2). 341–351. 22 indexed citations
6.
Ambroso, Jeffrey L., Gino Brunori, Ian Francis, et al.. (2015). Effects of mid-respiratory chain inhibition on mitochondrial function in vitro and in vivo. Toxicology Research. 5(1). 136–150. 8 indexed citations
7.
Vacchi‐Suzzi, Caterina, Yasmina Bauer, Brian R. Berridge, et al.. (2012). Perturbation of microRNAs in Rat Heart during Chronic Doxorubicin Treatment. PLoS ONE. 7(7). e40395–e40395. 80 indexed citations
8.
Pointon, Amy, Tracy Walker, Jinli Luo, et al.. (2010). Doxorubicin In Vivo Rapidly Alters Expression and Translation of Myocardial Electron Transport Chain Genes, Leads to ATP Loss and Caspase 3 Activation. PLoS ONE. 5(9). e12733–e12733. 110 indexed citations
9.
Gant, Timothy W., Ursula Lutz, Joel D. Parry, et al.. (2009). Two electron reduction of 2,3-dimethoxy-1,4-naphthoquinone metabolism in vivo prevents redox stress but interaction with the electron transport chain may be a mechanism of toxicity. Toxicology Letters. 189. S119–S119. 1 indexed citations
10.
Parry, Joel D., Amy Pointon, Ursula Lutz, et al.. (2009). Pivotal Role for Two Electron Reduction in 2,3-Dimethoxy-1,4-naphthoquinone and 2-Methyl-1,4-naphthoquinone Metabolism and Kinetics in Vivo That Prevents Liver Redox Stress. Chemical Research in Toxicology. 22(4). 717–725. 14 indexed citations
11.
Shikama, Noriko, Chang‐Woo Lee, Stephen L. France, et al.. (1999). A Novel Cofactor for p300 that Regulates the p53 Response. Molecular Cell. 4(3). 365–376. 173 indexed citations
12.
Lyon, Jonathan J. & Nicholas B. La Thangue. (1997). Chromatin research gathers pace. Trends in Cell Biology. 7(10). 389–389. 8 indexed citations
14.
Lyon, Jonathan J. & Roger J. Watson. (1995). Conditional inhibition of erythroid differentiation by c-Myb/oestrogen receptor fusion proteins. Differentiation. 59(3). 171–178. 11 indexed citations
15.
Lyon, Jonathan J., et al.. (1994). The Role of Myb Proteins in Normal and Neoplastic Cell Proliferation. Critical Reviews™ in Oncogenesis. 5(4). 373–388. 45 indexed citations
16.
Wukich, Dane K., et al.. (1989). Cardiac Isoenzyme Values After Total Joint Arthroplasty. Clinical Orthopaedics and Related Research. 242(242). 232–240. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026